Skip to content

"A study to screen the presence of Prameha Purvaroopa (Pre-Clinical features) in newly diagnosed Type 2 Diabetes Mellitus patients ."

"A Retrospective cohort study to screen the presence of Prameha Purvaroopa (Pre-Clinical features) among newly diagnosed patients of Type 2 Diabetes." - RCSPPP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/10/021799
Enrollment
300
Registered
2019-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Sponsors

State Ayurvedic College And Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Any one of either gender between 30 to 60 years diagnosed recently (within one year from the date of recruitment ) for having diabetes mellitus.( to be confirmed by observation of previous investigation followed by a new blood sugar investigation at the time of recruitment ) 2. Patient who are fulfilling the criteria one and not having any cognitive impairment making a retrospective recall, difficult. 3. Patient fulfilling the inclusion criteria one and two and are willing to participate in the proposed observational study.

Exclusion criteria

Exclusion criteria: 1. Patient not complying to any of the criteria as are specified in inclusion category. 2. Those subjects who have co-existences illness beside diabetes and which may interfere in the symptoms presentation will be excluded from the study ex. UTI, Neuropathy , Hyperthyroidism ,Hypothyroidism , vitamin B Complex deficiency etc.

Design outcomes

Primary

MeasureTime frame
Primary end point -1.Establishment of presence ofprameh specific purvaroopa,in newly diagnosed diabetic population upon their retrospective screening . Secondary end point -1.To establish those purvaroopa which appear earliest in the process of pathogenesis this will help us understanding the earliest warning sign for upcoming prameh. 2- To establish the heterogeneousity of diabetic population on the basis of differential presence of purvaroopa in the diabetic population. Timepoint: 1 year

Secondary

MeasureTime frame
Secondary end point -1.To establish those purvaroopa which appear earliest in the process of pathogenesis this will help us understanding the earliest warning sign for upcoming prameh. 2- To establish the heterogeneousity of diabetic population on the basis of differential presence of purvaroopa in the diabetic population. Timepoint: 1 year

Countries

India

Contacts

Public ContactSanjeev Rastogi

State Ayurvedic college and Hospital Lucknow U.P.

rastogisanjeev@rediffmail.com9415022955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026